Glycated Haemoglobin Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.

The global market for Glycated Haemoglobin Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Glycated Haemoglobin Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Glycated Haemoglobin Testing by region & country, by Type, and by Application.

The Glycated Haemoglobin Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Haemoglobin Testing.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Glycated Haemoglobin Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Glycated Haemoglobin Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Glycated Haemoglobin Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Glycated Haemoglobin Testing Product Introduction
    1.2 Global Glycated Haemoglobin Testing Market Size Forecast
    1.3 Glycated Haemoglobin Testing Market Trends & Drivers
        1.3.1 Glycated Haemoglobin Testing Industry Trends
        1.3.2 Glycated Haemoglobin Testing Market Drivers & Opportunity
        1.3.3 Glycated Haemoglobin Testing Market Challenges
        1.3.4 Glycated Haemoglobin Testing Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Glycated Haemoglobin Testing Players Revenue Ranking (2023)
    2.2 Global Glycated Haemoglobin Testing Revenue by Company (2019-2024)
    2.3 Key Companies Glycated Haemoglobin Testing Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Glycated Haemoglobin Testing Product Offered
    2.5 Key Companies Time to Begin Mass Production of Glycated Haemoglobin Testing
    2.6 Glycated Haemoglobin Testing Market Competitive Analysis
        2.6.1 Glycated Haemoglobin Testing Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Glycated Haemoglobin Testing Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycated Haemoglobin Testing as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Lab Based Test
        3.1.2 Point-of-care Test
    3.2 Global Glycated Haemoglobin Testing Sales Value by Type
        3.2.1 Global Glycated Haemoglobin Testing Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Glycated Haemoglobin Testing Sales Value, by Type (2019-2030)
        3.2.3 Global Glycated Haemoglobin Testing Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Diagnostic Centers
        4.1.3 Academic and Research Institutes
        4.1.4 Others
    4.2 Global Glycated Haemoglobin Testing Sales Value by Application
        4.2.1 Global Glycated Haemoglobin Testing Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Glycated Haemoglobin Testing Sales Value, by Application (2019-2030)
        4.2.3 Global Glycated Haemoglobin Testing Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Glycated Haemoglobin Testing Sales Value by Region
        5.1.1 Global Glycated Haemoglobin Testing Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Glycated Haemoglobin Testing Sales Value by Region (2019-2024)
        5.1.3 Global Glycated Haemoglobin Testing Sales Value by Region (2025-2030)
        5.1.4 Global Glycated Haemoglobin Testing Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Glycated Haemoglobin Testing Sales Value, 2019-2030
        5.2.2 North America Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Glycated Haemoglobin Testing Sales Value, 2019-2030
        5.3.2 Europe Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Glycated Haemoglobin Testing Sales Value, 2019-2030
        5.4.2 Asia Pacific Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Glycated Haemoglobin Testing Sales Value, 2019-2030
        5.5.2 South America Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Glycated Haemoglobin Testing Sales Value, 2019-2030
        5.6.2 Middle East & Africa Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Glycated Haemoglobin Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Glycated Haemoglobin Testing Sales Value
    6.3 United States
        6.3.1 United States Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.3.2 United States Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.4.2 Europe Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.5.2 China Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.6.2 Japan Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.7.2 South Korea Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.8.2 Southeast Asia Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Glycated Haemoglobin Testing Sales Value, 2019-2030
        6.9.2 India Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Glycated Haemoglobin Testing Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bio-Rad Laboratories
        7.1.1 Bio-Rad Laboratories Profile
        7.1.2 Bio-Rad Laboratories Main Business
        7.1.3 Bio-Rad Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
        7.1.4 Bio-Rad Laboratories Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.1.5 Bio-Rad Laboratories Recent Developments
    7.2 Bayer
        7.2.1 Bayer Profile
        7.2.2 Bayer Main Business
        7.2.3 Bayer Glycated Haemoglobin Testing Products, Services and Solutions
        7.2.4 Bayer Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.2.5 Bayer Recent Developments
    7.3 Arkray
        7.3.1 Arkray Profile
        7.3.2 Arkray Main Business
        7.3.3 Arkray Glycated Haemoglobin Testing Products, Services and Solutions
        7.3.4 Arkray Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.3.5 Chek Diagnostics Recent Developments
    7.4 Chek Diagnostics
        7.4.1 Chek Diagnostics Profile
        7.4.2 Chek Diagnostics Main Business
        7.4.3 Chek Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
        7.4.4 Chek Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.4.5 Chek Diagnostics Recent Developments
    7.5 Diazyme Laboratories
        7.5.1 Diazyme Laboratories Profile
        7.5.2 Diazyme Laboratories Main Business
        7.5.3 Diazyme Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
        7.5.4 Diazyme Laboratories Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.5.5 Diazyme Laboratories Recent Developments
    7.6 X Lite-On Technology
        7.6.1 X Lite-On Technology Profile
        7.6.2 X Lite-On Technology Main Business
        7.6.3 X Lite-On Technology Glycated Haemoglobin Testing Products, Services and Solutions
        7.6.4 X Lite-On Technology Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.6.5 X Lite-On Technology Recent Developments
    7.7 TaiDoc Technology
        7.7.1 TaiDoc Technology Profile
        7.7.2 TaiDoc Technology Main Business
        7.7.3 TaiDoc Technology Glycated Haemoglobin Testing Products, Services and Solutions
        7.7.4 TaiDoc Technology Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.7.5 TaiDoc Technology Recent Developments
    7.8 Trinity Biotech
        7.8.1 Trinity Biotech Profile
        7.8.2 Trinity Biotech Main Business
        7.8.3 Trinity Biotech Glycated Haemoglobin Testing Products, Services and Solutions
        7.8.4 Trinity Biotech Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.8.5 Trinity Biotech Recent Developments
    7.9 Siemens Healthcare
        7.9.1 Siemens Healthcare Profile
        7.9.2 Siemens Healthcare Main Business
        7.9.3 Siemens Healthcare Glycated Haemoglobin Testing Products, Services and Solutions
        7.9.4 Siemens Healthcare Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.9.5 Siemens Healthcare Recent Developments
    7.10 Ceragem Medisys
        7.10.1 Ceragem Medisys Profile
        7.10.2 Ceragem Medisys Main Business
        7.10.3 Ceragem Medisys Glycated Haemoglobin Testing Products, Services and Solutions
        7.10.4 Ceragem Medisys Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.10.5 Ceragem Medisys Recent Developments
    7.11 Tosoh Bioscience
        7.11.1 Tosoh Bioscience Profile
        7.11.2 Tosoh Bioscience Main Business
        7.11.3 Tosoh Bioscience Glycated Haemoglobin Testing Products, Services and Solutions
        7.11.4 Tosoh Bioscience Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.11.5 Tosoh Bioscience Recent Developments
    7.12 DiaSys Diagnostic Systems
        7.12.1 DiaSys Diagnostic Systems Profile
        7.12.2 DiaSys Diagnostic Systems Main Business
        7.12.3 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Products, Services and Solutions
        7.12.4 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.12.5 DiaSys Diagnostic Systems Recent Developments
    7.13 Erba Mannheim
        7.13.1 Erba Mannheim Profile
        7.13.2 Erba Mannheim Main Business
        7.13.3 Erba Mannheim Glycated Haemoglobin Testing Products, Services and Solutions
        7.13.4 Erba Mannheim Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.13.5 Erba Mannheim Recent Developments
    7.14 Daiichi Biotech
        7.14.1 Daiichi Biotech Profile
        7.14.2 Daiichi Biotech Main Business
        7.14.3 Daiichi Biotech Glycated Haemoglobin Testing Products, Services and Solutions
        7.14.4 Daiichi Biotech Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.14.5 Daiichi Biotech Recent Developments
    7.15 Human Diagnostics
        7.15.1 Human Diagnostics Profile
        7.15.2 Human Diagnostics Main Business
        7.15.3 Human Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
        7.15.4 Human Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.15.5 Human Diagnostics Recent Developments
    7.16 EKF Diagnostics
        7.16.1 EKF Diagnostics Profile
        7.16.2 EKF Diagnostics Main Business
        7.16.3 EKF Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
        7.16.4 EKF Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.16.5 EKF Diagnostics Recent Developments
    7.17 Mindray Medical
        7.17.1 Mindray Medical Profile
        7.17.2 Mindray Medical Main Business
        7.17.3 Mindray Medical Glycated Haemoglobin Testing Products, Services and Solutions
        7.17.4 Mindray Medical Glycated Haemoglobin Testing Revenue (US$ Million) & (2019-2024)
        7.17.5 Mindray Medical Recent Developments

 8 Industry Chain Analysis
    8.1 Glycated Haemoglobin Testing Industrial Chain
    8.2 Glycated Haemoglobin Testing Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Glycated Haemoglobin Testing Sales Model
        8.5.2 Sales Channel
        8.5.3 Glycated Haemoglobin Testing Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Glycated Haemoglobin Testing Market Trends
    Table 2. Glycated Haemoglobin Testing Market Drivers & Opportunity
    Table 3. Glycated Haemoglobin Testing Market Challenges
    Table 4. Glycated Haemoglobin Testing Market Restraints
    Table 5. Global Glycated Haemoglobin Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Glycated Haemoglobin Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Glycated Haemoglobin Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Glycated Haemoglobin Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Glycated Haemoglobin Testing
    Table 10. Global Glycated Haemoglobin Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycated Haemoglobin Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Glycated Haemoglobin Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Glycated Haemoglobin Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Glycated Haemoglobin Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Glycated Haemoglobin Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Glycated Haemoglobin Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Glycated Haemoglobin Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Glycated Haemoglobin Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Glycated Haemoglobin Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Glycated Haemoglobin Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Glycated Haemoglobin Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Glycated Haemoglobin Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Glycated Haemoglobin Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Glycated Haemoglobin Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Glycated Haemoglobin Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Glycated Haemoglobin Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Glycated Haemoglobin Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Glycated Haemoglobin Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Glycated Haemoglobin Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bio-Rad Laboratories Basic Information List
    Table 32. Bio-Rad Laboratories Description and Business Overview
    Table 33. Bio-Rad Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Bio-Rad Laboratories (2019-2024)
    Table 35. Bio-Rad Laboratories Recent Developments
    Table 36. Bayer Basic Information List
    Table 37. Bayer Description and Business Overview
    Table 38. Bayer Glycated Haemoglobin Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Bayer (2019-2024)
    Table 40. Bayer Recent Developments
    Table 41. Arkray Basic Information List
    Table 42. Arkray Description and Business Overview
    Table 43. Arkray Glycated Haemoglobin Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Arkray (2019-2024)
    Table 45. Arkray Recent Developments
    Table 46. Chek Diagnostics Basic Information List
    Table 47. Chek Diagnostics Description and Business Overview
    Table 48. Chek Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Chek Diagnostics (2019-2024)
    Table 50. Chek Diagnostics Recent Developments
    Table 51. Diazyme Laboratories Basic Information List
    Table 52. Diazyme Laboratories Description and Business Overview
    Table 53. Diazyme Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Diazyme Laboratories (2019-2024)
    Table 55. Diazyme Laboratories Recent Developments
    Table 56. X Lite-On Technology Basic Information List
    Table 57. X Lite-On Technology Description and Business Overview
    Table 58. X Lite-On Technology Glycated Haemoglobin Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of X Lite-On Technology (2019-2024)
    Table 60. X Lite-On Technology Recent Developments
    Table 61. TaiDoc Technology Basic Information List
    Table 62. TaiDoc Technology Description and Business Overview
    Table 63. TaiDoc Technology Glycated Haemoglobin Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of TaiDoc Technology (2019-2024)
    Table 65. TaiDoc Technology Recent Developments
    Table 66. Trinity Biotech Basic Information List
    Table 67. Trinity Biotech Description and Business Overview
    Table 68. Trinity Biotech Glycated Haemoglobin Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Trinity Biotech (2019-2024)
    Table 70. Trinity Biotech Recent Developments
    Table 71. Siemens Healthcare Basic Information List
    Table 72. Siemens Healthcare Description and Business Overview
    Table 73. Siemens Healthcare Glycated Haemoglobin Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Siemens Healthcare (2019-2024)
    Table 75. Siemens Healthcare Recent Developments
    Table 76. Ceragem Medisys Basic Information List
    Table 77. Ceragem Medisys Description and Business Overview
    Table 78. Ceragem Medisys Glycated Haemoglobin Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Ceragem Medisys (2019-2024)
    Table 80. Ceragem Medisys Recent Developments
    Table 81. Tosoh Bioscience Basic Information List
    Table 82. Tosoh Bioscience Description and Business Overview
    Table 83. Tosoh Bioscience Glycated Haemoglobin Testing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Tosoh Bioscience (2019-2024)
    Table 85. Tosoh Bioscience Recent Developments
    Table 86. DiaSys Diagnostic Systems Basic Information List
    Table 87. DiaSys Diagnostic Systems Description and Business Overview
    Table 88. DiaSys Diagnostic Systems Glycated Haemoglobin Testing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of DiaSys Diagnostic Systems (2019-2024)
    Table 90. DiaSys Diagnostic Systems Recent Developments
    Table 91. Erba Mannheim Basic Information List
    Table 92. Erba Mannheim Description and Business Overview
    Table 93. Erba Mannheim Glycated Haemoglobin Testing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Erba Mannheim (2019-2024)
    Table 95. Erba Mannheim Recent Developments
    Table 96. Daiichi Biotech Basic Information List
    Table 97. Daiichi Biotech Description and Business Overview
    Table 98. Daiichi Biotech Glycated Haemoglobin Testing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Daiichi Biotech (2019-2024)
    Table 100. Daiichi Biotech Recent Developments
    Table 101. Human Diagnostics Basic Information List
    Table 102. Human Diagnostics Description and Business Overview
    Table 103. Human Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Human Diagnostics (2019-2024)
    Table 105. Human Diagnostics Recent Developments
    Table 106. EKF Diagnostics Basic Information List
    Table 107. EKF Diagnostics Description and Business Overview
    Table 108. EKF Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of EKF Diagnostics (2019-2024)
    Table 110. EKF Diagnostics Recent Developments
    Table 111. Mindray Medical Basic Information List
    Table 112. Mindray Medical Description and Business Overview
    Table 113. Mindray Medical Glycated Haemoglobin Testing Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Glycated Haemoglobin Testing Business of Mindray Medical (2019-2024)
    Table 115. Mindray Medical Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Glycated Haemoglobin Testing Downstream Customers
    Table 119. Glycated Haemoglobin Testing Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Glycated Haemoglobin Testing Product Picture
    Figure 2. Global Glycated Haemoglobin Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Glycated Haemoglobin Testing Report Years Considered
    Figure 5. Global Glycated Haemoglobin Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Glycated Haemoglobin Testing Revenue in 2023
    Figure 7. Glycated Haemoglobin Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Lab Based Test Picture
    Figure 9. Point-of-care Test Picture
    Figure 10. Global Glycated Haemoglobin Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Glycated Haemoglobin Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Diagnostic Centers
    Figure 14. Product Picture of Academic and Research Institutes
    Figure 15. Product Picture of Others
    Figure 16. Global Glycated Haemoglobin Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Glycated Haemoglobin Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Glycated Haemoglobin Testing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Glycated Haemoglobin Testing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Glycated Haemoglobin Testing Sales Value (%), (2019-2030)
    Figure 29. United States Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Glycated Haemoglobin Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Glycated Haemoglobin Testing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Glycated Haemoglobin Testing Sales Value by Application (%), 2023 VS 2030
    Figure 50. Glycated Haemoglobin Testing Industrial Chain
    Figure 51. Glycated Haemoglobin Testing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.

The global market for Glycated Haemoglobin Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Glycated Haemoglobin Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Glycated Haemoglobin Testing by region & country, by Type, and by Application.

The Glycated Haemoglobin Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Haemoglobin Testing.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Glycated Haemoglobin Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Glycated Haemoglobin Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Glycated Haemoglobin Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.